THE KETOGENIC DIET IS INEFFECTIVE IN PRECLINICAL MODELS OF IDH1 WILD-TYPE AND IDH1 MUTANT GLIOMA

被引：0
|
作者：
Javier, Rodrigo [1 ]
Horbinski, Craig [2 ]
机构：
[1] Northwestern Feinberg Sch Med, Chicago, IL USA
[2] Northwestern Feinberg Sch Med, Dept Pathol, Chicago, IL USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TAMI-48
引用
收藏
页码：208 / 208
页数：1
相关论文
共 50 条
  • [1] The Ketogenic Diet is Ineffective in Preclinical Models of IDH1 Wild-type and IDH1 Mutant Glioma
    Horbinski, Craig
    Javier, Rodrigo
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (06): : 563 - 563
  • [2] The Preclinical Efficacy Of Ketogenic Diet In IDH1 Wild-type And Mutant Gliomas
    Javier, Rodrigo
    Mirkov, Snezana
    Horbinski, Craig
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2020, 79 (06): : 667 - 667
  • [3] Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma
    Sun, Chao
    Xiao, Liming
    Zhao, Yuanlin
    Shi, Jiankuan
    Yuan, Yuan
    Gu, Yu
    Zhang, Feng
    Gao, Xing
    Yang, Ying
    Yang, Risheng
    Qin, Junhui
    Zhang, Jin
    Wang, Chao
    Wang, Yingmei
    Wang, Zhe
    Hu, Peizhen
    Chang, Ting
    Wang, Liang
    Wang, Gang
    Chen, Huangtao
    Li, Zhuyi
    Ye, Jing
    TRANSLATIONAL ONCOLOGY, 2020, 13 (04):
  • [4] Wild-type IDH1: A molecular target in IDH1 mutant cancers
    Wickenden, Julie A.
    Russell, Paul
    Smith, Amy
    Henley, Tom
    Elliott, Jane
    Gitterman, Dan
    Stockdale, Mark
    Schofield, Christine
    Torrance, Chris
    Moore, Jonathan D.
    CANCER RESEARCH, 2014, 74 (19)
  • [5] The efficacy of an unrestricted cycling ketogenic diet in preclinical models of IDH wild-type and IDH mutant glioma
    Javier, Rodrigo
    Wang, Wenxia
    Drumm, Michael
    McCortney, Kathleen
    Sarkaria, Jann N.
    Horbinski, Craig
    PLOS ONE, 2022, 17 (02):
  • [6] Comparison of Transcriptomic Analysis between IDH1 Mutant and Wild-type of Lower Grade Glioma
    Lee, MinWook
    Jin, Hoeyoung
    Kim, Suwan
    Ji, SeonYeong
    Song, SeokJung
    Koh, DooHyun
    Choi, JoungWan
    Park, JeongMan
    Lee, YunGyeon
    Jo, GaeHoon
    Kim, JongIl
    Sim, JeongMin
    Ahn, JuWon
    Park, YoungJoon
    Kwack, KyuBum
    FASEB JOURNAL, 2020, 34
  • [7] CHARACTERIZATION OF DIFFERENTIAL 5-HYDROXYMETHYLCYTOSINE IN IDH1 MUTANT VERSUS IDH1 WILD-TYPE HIGH-GRADE GLIOMAS
    Glowacka, Wioletta
    Jain, Harshika
    Okura, Makiko
    Maimaitiming, Abulizi
    Yasin, Mamatjan
    Farooq, Hamza
    Aldape, Kenneth
    Kongkham, Paul
    NEURO-ONCOLOGY, 2017, 19 : 95 - 95
  • [8] WILD-TYPE IDH1 INHIBITS FERROPTOSIS IN GLIOBLASTOMA
    Dunterman, Madeline
    Korimerla, Navyateja
    Murnan, Kevin
    Tommasini-Ghelfi, Serena
    Wahl, Daniel
    Stegh, Alexander
    NEURO-ONCOLOGY, 2024, 26
  • [9] IDH1 MUTATION SPECIFIC miRNA SIGNATURE PREDICTS FAVORABLE PROGNOSIS IN GLIOBLASTOMA WITH IDH1 WILD-TYPE
    Wang, Zheng
    Bao, Zhaoshi
    Jiang, Tao
    NEURO-ONCOLOGY, 2013, 15 : 91 - 91
  • [10] Mutant IDH1 and seizures in patients with glioma
    Chen, Hao
    Judkins, Jonathon
    Thomas, Cheddhi
    Wu, Meijing
    Khoury, Laith
    Benjamin, Carolina G.
    Pacione, Donato
    Golfinos, John G.
    Kumthekar, Priya
    Ghamsari, Farhad
    Chen, Li
    Lein, Pamela
    Chetkovich, Dane M.
    Snuderl, Matija
    Horbinski, Craig
    NEUROLOGY, 2017, 88 (19) : 1805 - 1813
12345